Covid-19 meeting: dexamethasone would reduce patient mortality by a third

Audio 04:16

Vehicles spray disinfectant while disinfecting a road in the midst of the coronavirus (Covid-19) outbreak in Moscow, Russia, May 1, 2020. Sergei Kiselyov / Moscow News Agency / REUTERS

By: Simon Rozé Follow

Like every Thursday, the editorial focus of RFI is devoted to the Covid-19 epidemic, still growing worldwide, more than 10 million cases and more than 500,000 deaths. We learned recently, a first treatment seems to have an effect on mortality, an anti-inflammatory, https: //www.medrxiv.org/content/10.1101/2020.06.22.20137273v1)) Results whose data are finally accessible to the scientific community and being verified by a peer-reviewed journal ... We owe them to the British clinical trial Recovery ... "target =" _ blank "> dexamethasone which would reduce mortality by a third of the most affected patients in the intensive care unit. Small effect, but effect all the same. Results whose data are finally available to the scientific community and are being verified by a peer-reviewed journal. British clinical trial Recovery, the same trial which, however, concluded this week that another treatment was ineffective.

  • Coronavirus
  • Health and Medicine